All companies
Visit website
IHEALTHSCREEN
OperatingiHealthScreen, Inc.
Healthcare
AI-driven disease screening software
Post-money valuation ⓘ
$25.2M
As of Aug 2023 · from iHealthScreen Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$184,789
Across 1 round since 2023
Latest share price
$2.63
iHealthScreen Common Stock 1 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$0
−$25K
2020
$0
$128K
2021
$0
$227K
2022
$0
$583K
2023
$660K
$162K
2024
$1.0M
−$18K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
$660,339
$1,022,675
Cost of goods sold
$0
$0
$0
$0
$0
$0
Gross margin
—
—
—
—
100%
100%
Net income
-$25,266
$127,972
$226,974
$582,882
$161,686
-$17,855
Taxes paid
$69,873
$6,172
$47,743
$15,100
$48,510
$97,347
Balance sheet
Cash
$252
$18,312
$290,668
$21,103
$19,975
$14,609
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$9,792
$137,177
$13,452
$108,262
$238,564
$328,366
Short-term debt
$81,984
$215,520
$82,801
$70,950
$48,650
$105,616
Long-term debt
$264,546
$130,412
$197,418
$278,058
$187,926
$193,653
Total liabilities
$346,530
$345,932
$280,219
$349,008
$236,576
$299,268
Other
Headcount
—
16
16
3
4
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.2M
post-money
iHealthScreen Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $184.8K / $1.2MInvestors 128Post-money $25.2M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 5 of 4 annual reports (FY2022–FY2025)
128 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 11 filings on EDGARSource: ManualCIK 0001968655Share price $2.63
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.